"Breakthrough in Flu Prevention: FDA Approves Nation's First mRNA Flu Vaccine In a significant step towards revolutionizing the fight against seasonal flu, the US Food and Drug Administration (FDA) has given its green light to the nation's first mRNA flu vaccine, developed by Moderna. The groundbreaking vaccine has been approved for use in two key age groups: individuals between 50 and 64 years old and those 65 years and older, who are often most vulnerable to severe flu complications. This cutting-edge vaccine leverages the same mRNA technology used in Moderna's COVID-19 vaccine, which has shown impressive efficacy in preventing severe illness. With the approval of this new flu vaccine, health experts hope to see a significant reduction in flu-related hospitalizations and deaths, particularly among the elderly population."
The Food and Drug Administration (FDA) late Wednesday approved the nation's first mRNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the shot for two separate age groups; people age 50 to 64, and for 65 years and older. Moderna said it will conduct a postmarket clinical trial to confirm the effectiveness in the...
